Spitzer, RL, Kroenke, K, Linzer, M, Hahn, SR, Williams, JB, deGruy, FV 3rd, et al.
Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA
1995; 274: 1511–7.
Üstun, TB, Ayuso-Mateos, JL, Chatterji, S, Mathers, C, Murray, CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry
2004; 184: 386–92.
Fernández, A, Bellón, Saameño JA, Pinto-Meza, A, Luciano, JV, Autonell, J, Palao, D, et al.
Burden of chronic physical conditions and mental disorders in primary care. Br J Psychiatry
2010; 196: 302–9.
Lerner, D, Adler, DA, Chang, H, Lapitsky, L, Hood, MY, Perissinotto, C, et al.
Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv
2004; 55: 1371–8.
Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry
2010; 71 (suppl E1): e04.
American Psychiatric Association. Practice Guideline for the Treatment of Major Depression Disorder. APA, 2000.
National Institute for Health and Clinical Excellence. Depression: The Treatment and Management of Depression In Adults. Clinical Guideline 90.
Kessler, RC, Berglund, P, Demler, O, Jin, R, Koretz, D, Merikangas, KR, et al.
The epidemiology of major depressive disorder: results from the National Comorbidity SurveyReplication (NCS-R). JAMA
2003; 289: 3095–105.
Simon, GE, Perlis, RH.
Personalized medicine for depression: can we match patients with treatments?
Am J Psychiatry
2010; 167: 1445–55.
Papakostas, GI, Fava, M.
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci
2008; 10: 439–51.
Frank, E, Cassano, GB, Rucci, P, Thompson, WK, Kraemer, HC, Fagiolini, A, et al.
Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med
2011; 41: 151–62.
De Rubeis, RJ, Hollon, SD, Amsterdam, JD, Shelton, RC, Young, PR, Salomon, RM, et al.
Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry
2005; 62: 409–16.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, et al.
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol
2006; 74: 658–70.
Kocsis, JH, Leon, AC, Markowitz, JC, Manber, R, Arnow, B, Klein, DN, et al.
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry
2009; 70: 354–61.
Fournier, JC, DeRubeis, RJ, Shelton, RC, Hollon, SD, Amsterdam, JD, Gallop, R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol
2009; 77: 775–87.
Menchetti, M, Bortolotti, B, Rucci, P, Scocco, P, Bombi, A, Berardi, D, et al.
Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design. BMC Psychiatry
2010; 10: 97.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) . APA, 1994.
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al.
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry
1998; 59 (suppl 20): 22–33.
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol
1967; 6: 278–96.
Klerman, GL, Weissman, MM, Rounsaville, BJ, Chevron, E. Interpersonal Psychotherapy of Depression. Basics Books, 1984.
Klerman, GL, Budman, S, Berwick, D, Weissman, MM, Damico-White, J, Demby, A, et al.
Efficacy of a brief psychosocial intervention for symptoms of stress and distress among patients in primary care. Med Care
1987; 25: 1078–88.
Mossey, JM, Knott, KA, Higgins, M, Talerico, K. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci
1996; 51: M172–8.
Neugebauer, R, Kline, J, Bleiberg, K, Baxi, L, Markowitz, JC, Rosing, M, et al.
Preliminary open trial of interpersonal counseling for subsyndromal depression following miscarriage. Depress Anxiety
2007; 24: 219–22.
Mundt, JC, Marks, IM, Shear, MK, Greist, JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry
2002; 180: 461–4.
Thase, ME, Entsuah, AR, Rudolph, RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry
2001; 178: 234–41.
McPartlin, GM, Reynolds, A, Anderson, C. A comparison of once daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice. Primary Care Psychiatry
1998; 4: 127–32.
Mynors-Wallis, LM, Gath, DH, Day, A, Baker, F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ
2000; 320: 26–30.
Kraemer, HC, Wilson, GT, Fairburn, CG, Agras, WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry
2002; 59: 877–83.
Pincus, T, Miles, C, Froud, R, Underwood, M, Carnes, D, Taylor, S. Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study. BMC Med Res Methodol
2011; 11: 14.
Sun, X, Briel, M, Busse, J, You, J, Akl, E, Mejza, F, et al.
Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ
2012; 344: e1553.
Kraemer, HC, Kupfer, DJ.
Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry
2006; 59: 990–6.
Mynors-Wallis, LM, Gath, DH, Lloyd-Thomas, AR, Tomlinson, D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ
1995; 310: 441–5.
Brown, C, Schulberg, HC, Madonia, MJ, Shear, MK, Houck, PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry
1996; 153: 1293–300.
Chilvers, C, Dewey, M, Fielding, K, Gretton, V, Miller, P, Palmer, B, et al.
Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ
2001; 322: 772–5.
Bortolotti, B, Menchetti, M, Bellini, F, Montaguti, MB, Berardi, D. Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. Gen Hosp Psychiatry
2008; 30: 293–302.
Brown, C, Schulberg, HC, Prigerson, HG. Factors associated with symptomatic improvement and recovery from major depression in primary care patients. Gen Hosp Psychiatry
2000; 22: 242–50.
You, S, Conner, KR.
Stressful life events and depressive symptoms: influences of gender, event severity, and depression history. J Nerv Ment Dis
2009; 197: 829–33.
Salminen, JK, Karlsson, H, Hietala, J, Kajander, J, Aalto, S, Markkula, J, et al.
Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom
2008; 77: 351–7.
Hegerl, U, Hautzinger, M, Mergl, R, Kohnen, R, Schütze, M, Scheunemann, W, et al.
Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol
2010; 13: 31–44.
Brookes, S, Whitely, E, Egger, M, Davey, Smith G, Mulheran, P, Peters, T. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol
2004; 57: 229–36.
Van, HL, Schoevers, RA, Dekker, J. Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. Harv Rev Psychiatry
2008; 16: 225–34.